Drug Shortage Report for ACT CELECOXIB

Last updated on 2019-04-11 History
Report ID 68583
Drug Identification Number 02420163
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CELECOXIB
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-01
Estimated end date 2019-03-30
Actual end date 2019-03-30
Shortage status Resolved
Updated date 2019-04-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-12-04 English Compare
v2 2018-12-04 French Compare
v3 2019-01-31 English Compare
v4 2019-01-31 French Compare
v5 2019-03-14 English Compare
v6 2019-03-14 French Compare
v7 2019-04-11 English Compare
v8 2019-04-11 French Compare